The APS Type 1 Foundation, with generous sponsorship by the Clinical Immunology Society and the National Institute of Allergy and Infectious Disease, hosted a FOCIS (Federation of Clinical Immunology Societies) Member Society Symposium at the FOCIS 2024 Annual Meeting in San Francisco on June 18th.
Over 120 clinicians and scientists attended. The speakers delivered incredible talks about cutting-edge research relating to APS Type 1, the AIRE gene, and the thymus. Vice-President Jennifer Orange opened the session with a presentation about the work of the Foundation and our incredible community.
Thank you to Drs. Anderson and Lionakis for helping to make this incredible opportunity possible.
Session Agenda
Landscape of TEC Development and Differentiation
Corey Miller, MD, PhD
Assistant Professor, UCSF
TEC Differentiation
Matthieu Giraud, PhD
Senior Researcher, Nantes University
Dynamics of Thymic Selection
Ellen Robey, PhD
Professor, University of California, Berkeley
Human TEC Development
Audrey Parent, PhD
Assistant Professor, University of California, San Francisco
High Throughput Screening of APS1 and Translation
Aaron Bodansky, MD,
UCSF Clinical Fellow, University of California, San Francisco
B Cells as Professional APCs in Autoimmunity
Bill Robinson, MD, PhD
Professor, Stanford
Genetics of AIRE-Deficiency
Sebastian Ochoa, MD
Assistant Professor, Baylor College of Medicine
Clinical Trial for APS1
Mihalis Lionakis MD, ScD
Senior Investigator, NIAID